ERBB2 and breast carcinoma: First, the effect of EVs on the cancer cell‐killing ability of activated T cells was examined using a co‐culture system with BT‐474 breast cancer cells and CD8+ T cells mediated by anti‐HER2/anti‐CD3E bispecific antibody (Figure 5g).